Cowen Financial Products LLC 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-02 12:35 pm Sale | 2023-12-29 | 13G | scPharmaceuticals Inc. SCPH | Cowen Financial Products LLC | 0 0.000% | -2,407,562 (Position Closed) | Filing |
| 2023-02-27 10:06 am Purchase | 2023-02-16 | 13G | scPharmaceuticals Inc. SCPH | Cowen Financial Products LLC | 2,407,562 7.070% | 2,407,562 (New Position) | Filing |